Your browser doesn't support javascript.
loading
Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model.
Hassannia, Hadi; Amiri, Mohammad Mehdi; Ghaedi, Mojgan; Sharifian, Ramezan-Ali; Golsaz-Shirazi, Forough; Jeddi-Tehrani, Mahmood; Shokri, Fazel.
Afiliação
  • Hassannia H; Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari P.O. Box 48157-33971, Iran.
  • Amiri MM; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran P.O. Box 14155-6559, Iran.
  • Ghaedi M; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran P.O. Box 14155-6559, Iran.
  • Sharifian RA; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran P.O. Box 14155-6559, Iran.
  • Golsaz-Shirazi F; Department of Hematology and Oncology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran P.O. Box 14197-33141, Iran.
  • Jeddi-Tehrani M; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran P.O. Box 14155-6559, Iran.
  • Shokri F; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran P.O. Box 19839-69412, Iran.
Cancers (Basel) ; 14(23)2022 Nov 26.
Article em En | MEDLINE | ID: mdl-36497309

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article